NCT07021066 2026-04-15Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid TumorsSystImmune Inc.Phase 1 Recruiting160 enrolled
NCT07458347 2026-04-15A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) MutationKestrel Therapeutics, Inc.Phase 1 Recruiting145 enrolled
NCT07107750 2026-04-03Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract CancerWashington University School of MedicinePhase 1 Recruiting48 enrolled
NCT06451497 2026-04-02This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid TumorsZumutor Biologics Inc.Phase 1 Recruiting100 enrolled
NCT04234113 2026-03-27Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsSotio Biotech Inc.Phase 1 Terminated115 enrolled 43 charts